DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Apr 10, 2025 · 1y ago · Accession 0001104659-25-033819
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Apr 10, 2025
- Report date
- May 19, 2025
- Document
- tm252345-3_def14a.htm
- Size
- 3.3 MB